TABLE 2

Recommended susceptibility-based Helicobacter pylori eradication therapy after failure of empiric therapy

Susceptibility testing resultsRecommended regimen
Clarithromycin-susceptibleClarithromycin triple therapy for 14 days
Clarithromycin-resistant, metronidazole-susceptibleMetronidazole triple therapy for 14 days
Clarithromycin- and metronidazole-resistant, levofloxacin-susceptiblePreferred: empiric therapy with bismuth quadruple therapy for 14 days
Alternative: levofloxacin triple therapy for 14 daysa
  • a If levofloxacin triple therapy is selected and fails, bismuth quadruple therapy is the next step.

  • Based on information from reference 15.